According to Corcept Therapeutics 's latest financial reports and stock price the company's current number of shares outstanding is 102,014,000. At the end of 2023 the company had 102,014,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.10 B | -5.28% |
2022 | 0.10 B | -5.31% |
2021 | 0.11 B | -2.22% |
2020 | 0.11 B | 1.73% |
2019 | 0.11 B | -0.73% |
2018 | 0.11 B | 0.72% |
2017 | 0.11 B | 3.36% |
2016 | 0.11 B | 2.02% |
2015 | 0.10 B | 7.24% |
2014 | 0.10 B | 1.32% |
2013 | 99.81 M | 0.74% |
2012 | 99.08 M | 17.69% |
2011 | 84.18 M | 16.85% |
2010 | 72.04 M | 44.77% |
2009 | 49.76 M | 2.07% |
2008 | 48.75 M | 33.18% |
2007 | 36.6 M | 61.13% |
2006 | 22.71 M | 0.43% |
2005 | 22.62 M | 0.39% |
2004 | 22.53 M | 108.08% |
2003 | 10.82 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 2,407,200,000 | 2,259.68% | ๐บ๐ธ USA |
Novartis NVS | 2,044,000,000 | 1,903.65% | ๐จ๐ญ Switzerland |
Pfizer PFE | 5,647,000,000 | 5,435.51% | ๐บ๐ธ USA |
Eli Lilly LLY | 949,379,000 | 830.64% | ๐บ๐ธ USA |
Merck MRK | 2,554,166,667 | 2,403.74% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | 2,023,000,000 | 1,883.06% | ๐บ๐ธ USA |
MannKind Corp MNKD | 268,732,000 | 163.43% | ๐บ๐ธ USA |
Esperion Therapeutics ESPR | 111,869,478 | 9.66% | ๐บ๐ธ USA |
BioMarin Pharmaceutical BMRN | 188,219,000 | 84.50% | ๐บ๐ธ USA |